|
28 Aug 2025 |
SIS
|
Consensus Share Price Target
|
359.95 |
453.25 |
- |
25.92 |
buy
|
|
|
|
|
31 Jul 2025
|
SIS
|
Motilal Oswal
|
359.95
|
450.00
|
386.40
(-6.85%)
|
25.02 |
Buy
|
|
|
SIS (SECIS)’s 1QFY26 revenue was up 13.4% YoY/3.5% QoQ at INR35.4b vs. our estimate of INR34.5b. Revenue growth was aided by 18.9% YoY CC growth in Facility Management, whereas India Security/International Security posted 9.2%/12.1% growth YoY.
|
|
05 May 2025
|
SIS
|
Keynote Capitals Ltd
|
359.95
|
361.00
|
325.35
(10.63%)
|
Target met |
Buy
|
|
|
Quarterly Update Q4FY25
|
|
01 May 2025
|
SIS
|
Motilal Oswal
|
359.95
|
400.00
|
337.50
(6.65%)
|
Target met |
Buy
|
|
|
SIS (SECIS)’s 4QFY25 revenue was up 9.3% YoY/1.9% QoQ at INR34.27b, largely in line with our estimate of INR34.6b. Revenue growth was aided by 12.9% YoY growth in Facility management, whereas India Security/International security posted 9.6%/7.7% growth YoY.
|
|
30 Jan 2025
|
SIS
|
Keynote Capitals Ltd
|
359.95
|
414.00
|
330.80
(8.81%)
|
15.02 |
Buy
|
|
|
Quarterly Update Q3FY25
|
|
31 Oct 2024
|
SIS
|
Keynote Capitals Ltd
|
359.95
|
483.00
|
402.00
(-10.46%)
|
34.19 |
Buy
|
|
|
Quarterly Update Q2FY25
|
|
30 Oct 2024
|
SIS
|
Axis Direct
|
359.95
|
540.00
|
400.85
(-10.20%)
|
50.02 |
Buy
|
|
|
Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock
|
|
29 Oct 2024
|
SIS
|
Motilal Oswal
|
359.95
|
480.00
|
386.05
(-6.76%)
|
33.35 |
Buy
|
|
|
SIS (SECIS)’s 2QFY25 revenue was up 6.3% YoY/4.4% QoQ at INR32.68b, largely in line with our estimate of INR34.51b.
|
|
29 Jul 2024
|
SIS
|
Keynote Capitals Ltd
|
359.95
|
585.00
|
421.25
(-14.55%)
|
|
Buy
|
|
|
Quarterly Update Q1FY25
|
|
26 Jul 2024
|
SIS
|
Axis Direct
|
359.95
|
540.00
|
419.75
(-14.25%)
|
|
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
06 May 2024
|
SIS
|
Keynote Capitals Ltd
|
359.95
|
441.00
|
440.50
(-18.29%)
|
Target met |
Buy
|
|
|
Quarterly Update Q4FY24
|
|
03 May 2024
|
SIS
|
Axis Direct
|
359.95
|
540.00
|
455.15
(-20.92%)
|
|
Buy
|
|
|
Recommendation: Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
01 Feb 2024
|
SIS
|
Keynote Capitals Ltd
|
359.95
|
741.00
|
488.50
(-26.32%)
|
|
Buy
|
|
|
Quarterly Update Q3FY24
|
|
01 Feb 2024
|
SIS
|
Axis Direct
|
359.95
|
540.00
|
488.50
(-26.32%)
|
|
Buy
|
|
|
Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
01 Nov 2023
|
SIS
|
Keynote Capitals Ltd
|
359.95
|
794.00
|
429.40
(-16.17%)
|
|
Buy
|
|
|
Quarterly Update Q2FY24
|
|
01 Nov 2023
|
SIS
|
Axis Direct
|
359.95
|
475.00
|
429.40
(-16.17%)
|
Target met |
Buy
|
|
|
Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
21 Sep 2023
|
SIS
|
Keynote Capitals Ltd
|
359.95
|
837.00
|
426.10
(-15.52%)
|
|
Buy
|
|
|
Initiating Coverage Report
|
|
28 Jul 2023
|
SIS
|
Axis Direct
|
359.95
|
475.00
|
434.65
(-17.19%)
|
Target met |
Buy
|
|
|
Recommendation: Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
05 May 2023
|
SIS
|
Axis Direct
|
359.95
|
425.00
|
383.35
(-6.10%)
|
Target met |
Buy
|
|
|
Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
06 Feb 2023
|
SIS
|
Axis Direct
|
359.95
|
425.00
|
345.95
(4.05%)
|
Target met |
Buy
|
|
|
Recommendation: Given the company's strong recovery potential backed by strong deal wins and improved client engagement, we maintain our BUY recommendation on the stock.
|
|
04 Nov 2022
|
SIS
|
Axis Direct
|
359.95
|
475.00
|
411.35
(-12.50%)
|
Target met |
Buy
|
|
|
We recommend a BUY rating on the stock and assign an 18x P/E multiple to its FY24E earnings of Rs 28.4/share which gives a TP of Rs 475/share, implying an upside of 15% from the CMP.
|